Indeed, a recent report suggested that higher levels of FYN protein are associated with chemo-resistance in ovarian cancer patients and that depletion of FYN significantly resensitizes ovarian cancer cells to platinum-based chemotherapy [43]. The gene discussed is FYN; the disease is ovarian carcinoma.